A previous Benzinga article reported erroneously that the FDA had already ruled on the Arena Pharmaceuticals ARNA drug for weight loss.
The ruling is not until Thursday.
The initial findings were released, in which the FDA said there were three noteworthy safety issues" found in the testing of rats.
Shares are down sharply on this news.
Benzinga regrets this error.
You Can't Afford Miss To Out On These Money Making Trading Ideas.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in